Skip to main content
NCBI home page
Journal of Anatomy logoLink to Journal of Anatomy
. 1975 Feb;119(Pt 1):19–37.

The development of nephrocalcinosis in the rat following injections of neutral sodium phosphate.

P Haase
PMCID: PMC1231612  PMID: 1133087

Abstract

The development of nephrocalcinosis in the rat following intraperitoneal injections of various concentrations of neutral sodium phosphate (pH 7-4) was studied using histology, histochemistry, electron microscopy and quantitative techniques. Daily injections of 0-5 M phosphate consistently produced nephrocalcinosis after 6 days or more. Calcium deposits were at first confined to the basement membranes of proximal tubules; but a longer course of injections, up to 10 days, resulted in additional basement membrane calcification in the outer cortes, and outer medulla, together with intra-luminal casts, often calcified, in the outer medulla and papilla. Calcification was not found in other organs such as liver, lung, heart or aorta. Results from quantitative estimations of total kidney calcium and phosphorus suggested that it was the calcium content which was important to the initiation of nephrocalcinosis. Ultrastructural changes, suggestive of degeneration or alteration in function, were found in mitochondria of proximal tubules in experimental animals before the onset of histologically evident nephrocalcinosis. Later changes, especially to the basal part of proximal tubular cells and their basal laminae, were thought to be consequent upon the mitochondrial changes. It is suggested that the initial renal damage was caused both directly, by a toxic effect of the phosphate load on the kidney and, indirectly, by stimulation of the parathyroid glands as a result of the hypocalcaemia and hyperphosphataemia which followed an injection of phosphate. Daily doses of 1 M phosphate for 3 days produced a type of nephrocalcinosis which was more typical of that reported by previous investigators, who used high doses of phosphate. Twice daily injections of 0-25 M phosphate for 6 days did not induce nephrocalcinosis, whereas 0-375 M phosphate given twice daily for 6 days produced only minimal calcium deposits compared with animals given 0-5 M phosphate once daily for the same period. This may have important clinical implications, since phosphate has been used to control hypercalcaemia of various etiologies.

Full text

PDF
19

Images in this article

22Fig. 1
on p.22
23Fig. 2
on p.23
24Fig. 3
on p.24
25Fig. 4
on p.25
26Fig. 5
on p.26
28Fig. 6
on p.28
29Fig. 7
on p.29
30Fig. 8
on p.30
32Fig. 9
on p.32
33Fig. 10
on p.33
34Fig. 11
on p.34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER R., REAVEN G., SAWYER J. Ground substance and calcification; the influence of dye binding on experimental nephrocalcinosis. J Urol. 1954 May;71(5):511–522. doi: 10.1016/S0022-5347(17)67819-4. [DOI] [PubMed] [Google Scholar]
  2. Bernheim C., Vischer T. Néphropathie tubulaire aiguë et calcifications radiologiques basculaires tardives après traitemtnt d'une hypercalcémie par administration intraveineuse de phosphates. Schweiz Med Wochenschr. 1968 Apr 27;98(17):641–645. [PubMed] [Google Scholar]
  3. Borle A. B. Kinetic analyses of calcium movements in cell cultures. IV. Effects of phosphate and parathyroid hormone in kidney cells. Endocrinology. 1970 Jun;86(6):1389–1393. doi: 10.1210/endo-86-6-1389. [DOI] [PubMed] [Google Scholar]
  4. Breuer R. I., LeBauer J. Caution in the use of phosphates in the treatment of severe hypercalcemia. J Clin Endocrinol Metab. 1967 May;27(5):695–698. doi: 10.1210/jcem-27-5-695. [DOI] [PubMed] [Google Scholar]
  5. CARONE F. A., EPSTEIN F. H., BECK D., LEVITIN The effects upon the kidney of transienthypercalcemia induced by parathyroid extract. Am J Pathol. 1960 Jan;36:77–103. [PMC free article] [PubMed] [Google Scholar]
  6. CAULFIELD J. B., SCHRAG P. E. ELECTRON MICROSCOPIC STUDY OF RENAL CALCIFICATION. Am J Pathol. 1964 Mar;44:365–381. [PMC free article] [PubMed] [Google Scholar]
  7. CRAIG J. M. Observations on the kidney after phosphate loading in the rat. Arch Pathol. 1959 Sep;68:306–315. [PubMed] [Google Scholar]
  8. Carey R. W., Schmitt G. W., Kopald H. H., Kantrowitz P. A. Massive extraskeletal calcification during phosphate treatment of hypercalcemia. Arch Intern Med. 1968 Aug;122(2):150–155. [PubMed] [Google Scholar]
  9. Clark I., Rivera-Cordero F. Prevention of phosphate-induced nephrocalcinosis by parathyroidectomy. Proc Soc Exp Biol Med. 1972 Mar;139(3):803–805. doi: 10.3181/00379727-139-36241. [DOI] [PubMed] [Google Scholar]
  10. Cohn D. V., Bawdon R., Eller G. The effect of parathyroid hormone in vivo on the accumulation of calcium and phosphate by kidney and on kidney mitochondrial function. J Biol Chem. 1967 Mar 25;242(6):1253–1264. [PubMed] [Google Scholar]
  11. Cohn D. V., Smaich A. F., Levy R. The inhibition of respiration and phosphorylation in kidney mitochondria by parathyroid hormone administered in vivo. J Biol Chem. 1966 Feb 25;241(4):889–894. [PubMed] [Google Scholar]
  12. DENT C. E. Some problems of hyperparathyroidism. Br Med J. 1962 Dec 8;2(5318):1495–1500. doi: 10.1136/bmj.2.5318.1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Drake T. G., Albright F., Castleman B. PARATHYROID HYPERPLASIA IN RABBITS PRODUCED BY PARENTERAL PHOSPHATE ADMINISTRATION. J Clin Invest. 1937 Mar;16(2):203–206. doi: 10.1172/JCI100848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. ENGFELDT B., GARDELL S., HELLSTROM J., IVEMARK B., RHODIN J., STRANDH J. Effect of experimentally induced hyperparathyroidism on renal function and structure. Acta Endocrinol (Copenh) 1958 Sep;29(1):15–26. doi: 10.1530/acta.0.0290015. [DOI] [PubMed] [Google Scholar]
  15. FOURMAN J. Two distinct forms of experimental nephrocalcinosis in the rat. Br J Exp Pathol. 1959 Oct;40:464–473. [PMC free article] [PubMed] [Google Scholar]
  16. GRIMES W. A. A phase contrast study of the mechanisms of renal calcification. J Urol. 1957 Nov;78(5):553–574. doi: 10.1016/S0022-5347(17)66476-0. [DOI] [PubMed] [Google Scholar]
  17. Ham A. W., Littner N., Drake T. G., Robertson E. C., Tisdall F. F. Physiological hypertrophy of the parathyroids, its cause and its relation to rickets. Am J Pathol. 1940 May;16(3):277–286. [PMC free article] [PubMed] [Google Scholar]
  18. LEHR D., KRUKOWSKI M. About the mechanism of myocardial necrosis induced by sodium phosphate and adrenal corticoid overdosage. Ann N Y Acad Sci. 1963 Apr 22;105:137–182. doi: 10.1111/j.1749-6632.1963.tb42978.x. [DOI] [PubMed] [Google Scholar]
  19. MOFFAT D. B. Demonstration of alkaline phosphatase and periodic acid-Schiff positive material in the same section. Stain Technol. 1958 Sep;33(5):225–228. doi: 10.3109/10520295809111854. [DOI] [PubMed] [Google Scholar]
  20. Nylen M. U., Eanes E. D., Termine J. D. Molecular and ultrastructural studies of non-crystalline calcium phosphates. Calcif Tissue Res. 1972;9(2):95–108. doi: 10.1007/BF02061948. [DOI] [PubMed] [Google Scholar]
  21. POLICARD A., COLLET A., DANIEL MOUSSARD H., PREGERMAIN S. [On nephrocalcinosis. Experimental research by electron microscope]. Presse Med. 1960 Oct 26;68:1735–1738. [PubMed] [Google Scholar]
  22. SCHNEIDER A. F., REAVEN E. P., REAVEN G. A comparison of renal calcification produced by parathyroid extract or calcium gluconate. Endocrinology. 1960 Dec;67:733–743. doi: 10.1210/endo-67-6-733. [DOI] [PubMed] [Google Scholar]
  23. Shackney S., Hasson J. Precipitous fall in serum calcium, hypotension, and acute renal failure after intravenous phosphate therapy for hypercalcemia. Report of two cases. Ann Intern Med. 1967 May;66(5):906–916. doi: 10.7326/0003-4819-66-5-906. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Anatomy are provided here courtesy of Anatomical Society of Great Britain and Ireland

RESOURCES